FDA Approved: ZETIA — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC to update/expand aspects of its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Homozygous Familial Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Zetia (ezetimibe)

Snippet

SUPPL AP for ZETIA (EZETIMIBE)